Published Research Alert: Gene Correction of LGMD2A Specific iPSCs for the Development of Targeted Autologous Cell Therapy

Coalition to Cure Calpain 3 (C3) is pleased to announce the publication of important research undertaken by Dr. Rita Perlingeiro, Professor of Medicine, University of Minnesota, and colleagues. The paper, titled “Gene Correction of LGMD2A Specific iPSCs for the Development of Targeted Autologous Cell Therapy,” was published in Molecular Therapy. 

The group used the technique CRISPR-Cas9 to correct mutations in the CAPN3 gene in cells derived from LGMD2A patient samples called induced pluripotent stem cells (iPSCs). After gene correction, the cells showed expression of the Calpain 3 protein at levels similar to non-LGMD2A cells. Gene corrected cells were then transplanted into the tibialis anterior muscle of a mouse model of LGMD2A.

Although stem cell-based therapies are still in very early stages of development for muscular dystrophies, the results in this paper suggest that this strategy may have potential as a therapy for LGMD2A.

This work was funded in part by C3, with the support of a generous grant from Beyond Labels and Limitations.

Click here to view the abstract on PubMed.gov

Recent Posts

  • Ruby Goldstein de Salazar Awarded C3 Travel Grant

    C3 awarded a Travel Grant to Ruby Goldstein de Salazar, a graduate student in Dr. Melissa Spencer’s laboratory at the University of California Los Angeles. Ms. Goldstein de Salazar traveled to Hiroshima, Japan in September 2026 to present her research at the 31st annual Congress of the World Muscle Society. Ms. Goldstein de Salazar’s presentation,... Read More
  • Djunda Ratenan-Peltier Awarded C3 Travel Grant

    C3 is pleased to announce that Djunda Ratenan-Peltier was awarded a Travel Grant for the presentation of her research at the international conference New Directions in Biology and Disease of Skeletal Muscle, which took place from June 7 to 10, 2026 in Fort Lauderdale, Florida. Ms. Ratenan-Peltier is a PhD student in Life Sciences at... Read More